A Phase 2 Study of Bortezomib Combined with Either Idarubicin/Cytarabine or Cytarabine/Etoposide in Children with Relapsed, Refractory or Secondary Acute Myeloid Leukemia: A Report from the Children's Oncology Group

T.M. Horton, J.P. Perentesis, A.S. Gamis, T.A. Alonzo, R.B. Gerbing, J. Ballard, K. Adlard, D.S. Howard, F.O. Smith, G. Jenkins, A. Kelder, G.J. Schuurhuis, J.A. Moscow

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1754-1760
JournalPediatric Blood and Cancer
Issue number10
Publication statusPublished - 2014

Cite this